Novartis's aircraft lands in Morristown the week the pharma giant expands US manufacturing

Novartis's Dassault Falcon 7X (HB-JFQ) was tracked flying from San Francisco to Morristown Municipal Airport on June 30, a 4-hour 57-minute hop that touched down at 20:33 UTC. The aircraft had arrived in the Bay Area on June 28, so this leg brings it back to the New Jersey hub that serves the company's East Hanover, New York-area operations.

If Novartis executives were aboard, the trip would arrive in the same seat of the company's US pharmaceutical arm the week after Novartis finalized its $23 billion US manufacturing and R&D expansion plan — a plan that, per a GlobeNewswire release on April 30, includes a seventh new facility in Morrisville, North Carolina, as well as a new biomedical research center in San Diego and radiotheranostics plants in Texas and Florida. The company's CEO Vas Narasimhan has been navigating a challenging Q1 earnings miss attributed to generic erosion of its blockbuster drug Entresto, as reported by Reuters.

The recent flight pattern shows a steady circuit: Basel to New Jersey, New Jersey to San Francisco, then back east. For a Swiss multinational that depends on rapid executive mobility across its global network, the Morristown airfield is a well-worn doorstep.